ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,554.32
2.23%
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs Yen
155.512
0.06%
Brent Oil
83.935
0.45%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Aevi Genomic Medicine Inc (GNMX)

  7. Aevi Genomic Medicine Inc (GNMX) ニュース

GNMX

Aevi Genomic Medicine (GNMX)

Aevi Genomic Medicine Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:GNMX
日付受信時刻ニュースソース見出しコード企業名
2020/02/1506 : 25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1500 : 57Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1420 : 01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1420 : 00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1420 : 00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1306 : 30Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 48Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 47Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 45Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 43Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 42Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 42Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 41Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/1305 : 40Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0802 : 58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0802 : 58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0802 : 57Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0606 : 26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0606 : 25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0606 : 23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0606 : 22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0606 : 20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0606 : 19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0606 : 17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0606 : 16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0606 : 14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
2020/02/0606 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GNMXAevi Genomic Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:GNMX

最近閲覧した銘柄

NASDAQ
MSFT
Microsoft
NYSE
JPM
JP Morgan Chase
FX
USDGBP
US Dollar vs Sterling
NYSE
DIS
Walt Disney
COIN
BTCUSD
Bitcoin
NYSE
MCD
McDonalds
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
XOM
Exxon Mobil
USOTC
ADDYY
Adidas (QX)
CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
GOOGL
Alphabet
USOTC
RHHBY
Roche (QX)
CCOM
US100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有